<MedlineCitation Status="Completed">
<MedlineID>10011168</MedlineID>
<PMID>311203</PMID>
<DateCreated>
<Year>1979</Year>
<Month>04</Month>
<Day>28</Day>
</DateCreated>
<DateCompleted>
<Year>1979</Year>
<Month>04</Month>
<Day>28</Day>
</DateCompleted>
<DateRevised>
<Year>2001</Year>
<Month>03</Month>
<Day>23</Day>
</DateRevised>
<Article>
<Journal>
<ISSN>0004-3591</ISSN>
<JournalIssue>
<Volume>22</Volume>
<Issue>3</Issue>
<PubDate>
<Year>1979</Year>
<Month>Mar</Month>
</PubDate>
</JournalIssue>
</Journal>
<ArticleTitle>Detection of low avidity anti-DNA antibodies in systemic lupus erythematosus.</ArticleTitle>
<Pagination>
<MedlinePgn>219-25</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>The binding of sonicated, radiolabeled DNA by systemic lupus erythematosus (SLE) sera was measured by a high sensitivity polyethylene glycol (PEG) precipitation assay. This method is considerably more sensitive than currently used techniques. The results suggest that a significant concentration of low avidity antibodies is present in SLE sera; however, these antibodies are not detected by conventional techniques.</AbstractText>
</Abstract>
<AuthorList>
<Author>
<LastName>Riley</LastName>
<ForeName>R L</ForeName>
<Initials>RL</Initials>
</Author>
<Author>
<LastName>McGrath</LastName>
<ForeName>H</ForeName>
<Initials>H</Initials>
<Suffix>Jr</Suffix>
</Author>
<Author>
<LastName>Taylor</LastName>
<ForeName>R P</ForeName>
<Initials>RP</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>Arthritis Rheum</MedlineTA>
<NlmUniqueID>0370605</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Antibodies, Antinuclear</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Antigen-Antibody Complex</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Polyethylene Glycols</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>10028-17-8</RegistryNumber>
<NameOfSubstance>Tritium</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName>Antibodies, Antinuclear</DescriptorName>
<QualifierName MajorTopicYN="Y">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Antibody Affinity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Antigen-Antibody Complex</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Human</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Lupus Erythematosus, Systemic</DescriptorName>
<QualifierName MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Methods</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Polyethylene Glycols</DescriptorName>
<QualifierName>diagnostic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Precipitation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Support, U.S. Gov't, P.H.S.</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Tritium</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Ultrafiltration</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
